74 related articles for article (PubMed ID: 21623702)
1. Enantioselective carbonyl reduction of eperisone in human liver microsomes.
Yoo HH; Kim NS; Kim MJ; Shin D; Shin JG; Kim DH
Xenobiotica; 2011 Sep; 41(9):758-63. PubMed ID: 21623702
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human cytochrome P450 enzymes involved in the biotransformation of eperisone.
Yoo HH; Kim NS; Lee J; Sohn DR; Jin C; Kim DH
Xenobiotica; 2009 Jan; 39(1):1-10. PubMed ID: 19219743
[TBL] [Abstract][Full Text] [Related]
3. The novel anticancer drug oracin: different stereospecificity and cooperativity for carbonyl reduction by purified human liver 11beta-hydroxysteroid dehydrogenase type 1.
Wsól V; Szotáková B; Skálová L; Maser E
Toxicology; 2004 May; 197(3):253-61. PubMed ID: 15033547
[TBL] [Abstract][Full Text] [Related]
4. Stereochemical aspects of carbonyl reduction of the original anticancer drug oracin by mouse liver microsomes and purified 11beta-hydroxysteroid dehydrogenase type 1.
Wsól V; Szotáková B; Skálová L; Maser E
Chem Biol Interact; 2003 Feb; 143-144():459-68. PubMed ID: 12604232
[TBL] [Abstract][Full Text] [Related]
5. Chiral inversion of RS-8359: a selective and reversible MAO-A inhibitor via oxido-reduction of keto-alcohol.
Itoh K; Hoshino K; Endo A; Asakawa T; Yamakami K; Noji C; Kosaka T; Tanaka Y
Chirality; 2006 Sep; 18(9):698-706. PubMed ID: 16823812
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study.
Cabitza P; Randelli P
Eur Rev Med Pharmacol Sci; 2008; 12(4):229-35. PubMed ID: 18727454
[TBL] [Abstract][Full Text] [Related]
7. Partial purification and characterization of a new human membrane-bound carbonyl reductase playing a role in the deactivation of the anticancer drug oracin.
Skarydová L; Skarka A; Novotná R; Zivná L; Martin HJ; Wsól V; Maser E
Toxicology; 2009 Oct; 264(1-2):52-60. PubMed ID: 19635524
[TBL] [Abstract][Full Text] [Related]
8. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344).
Park JS; Rhee SD; Kang NS; Jung WH; Kim HY; Kim JH; Kang SK; Cheon HG; Ahn JH; Kim KY
Biochem Pharmacol; 2011 Apr; 81(8):1028-35. PubMed ID: 21315688
[TBL] [Abstract][Full Text] [Related]
9. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1.
Odermatt A; Da Cunha T; Penno CA; Chandsawangbhuwana C; Reichert C; Wolf A; Dong M; Baker ME
Biochem J; 2011 Jun; 436(3):621-9. PubMed ID: 21453287
[TBL] [Abstract][Full Text] [Related]
10. Effects of bile acids on rat hepatic microsomal type I 11beta-hydroxysteroid dehydrogenase.
Maeda Y; Naganuma S; Niina I; Shinohara A; Koshimoto C; Kondo K; Chijiiwa K
Steroids; 2010 Feb; 75(2):164-8. PubMed ID: 19948178
[TBL] [Abstract][Full Text] [Related]
11. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
Marathe PH; Shen DD; Nelson WL
Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective aliphatic hydroxylations of racemic 1-hydroxy-3-methylcholanthrene by rat liver microsomes.
Shou MG; Yang SK
Chirality; 1990; 2(3):141-9. PubMed ID: 2252843
[TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of the enzymes involved in the metabolism of 1-furan-2-yl-3-pyridin-2-yl-propenone, an anti-inflammatory propenone compound.
Lee SK; Kim JH; Seo YM; Kim HC; Kang MJ; Jeong HG; Lee ES; Jeong TC
Arch Pharm Res; 2008 Jun; 31(6):764-70. PubMed ID: 18563359
[TBL] [Abstract][Full Text] [Related]
14. Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone.
Yang SI; Park HY; Lee SH; Lee SJ; Han OY; Lim SC; Jang CG; Lee WS; Shin YH; Kim JJ; Lee SY
Pharmacology; 2004 Jul; 71(3):150-6. PubMed ID: 15161997
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with eperisone in the treatment of acute low back pain.
Beltrame A; Grangiè S; Guerra L
Minerva Med; 2008 Aug; 99(4):347-52. PubMed ID: 18663343
[TBL] [Abstract][Full Text] [Related]
16. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes.
Yoon YJ; Kim KB; Kim H; Seo KA; Kim HS; Cha IJ; Kim EY; Liu KH; Shin JG
Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876
[TBL] [Abstract][Full Text] [Related]
17. Carbonyl reduction of bupropion in human liver.
Molnari JC; Myers AL
Xenobiotica; 2012 Jun; 42(6):550-61. PubMed ID: 22339467
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
19. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
Su X; Vicker N; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
Mol Cell Endocrinol; 2006 Mar; 248(1-2):214-7. PubMed ID: 16325333
[TBL] [Abstract][Full Text] [Related]
20. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
